Litcius/Paper detail

Osteoprotective effects of flavonoids: Evidence from <i>in vivo</i> and <i>in vitro</i> studies (Review)

Lili Cao, Jiawei Wang, Yujuan Zhang, Feng Tian, Chunfang Wang

2022Molecular Medicine Reports24 citationsDOIOpen Access PDF

Abstract

Osteoporosis is a systemic bone disease characterized by decreased bone mass and quality and bone micro‑architecture degradation. Its primary cause is disorder of bone metabolism: Over‑formation of osteoclasts, resulting in increased bone resorption and insufficient osteogenesis. Traditional herbal flavonoids can be used as alternative drugs to prevent and treat osteoporosis due to their wide range of sources, structural diversity and less adverse effects. The present paper reviewed six flavonoids, including quercetin, icariin, hesperitin, naringin, chrysin and pueraria, that promote bone formation and have been widely studied in the literature over the past five years, with the aim of providing novel ideas for the development of drugs for bone‑associated disease.

Topics & Concepts

OsteoporosisBone remodelingMedicineBone resorptionPharmacologyIn vivoMolecular medicineBioinformaticsInternal medicineBiologyCancerCell cycleBiotechnologyBone Metabolism and DiseasesMedicinal Plant Pharmacodynamics ResearchCytokine Signaling Pathways and Interactions
Osteoprotective effects of flavonoids: Evidence from <i>in vivo</i> and <i>in vitro</i> studies (Review) | Litcius